ABL Bio, Foreign Investors Net Buy 106,000 Shares... Stock Price Up 24.95%
ABL Bio has ranked among the top searched stocks for 6 days in the past month.
As of 1:30 PM on the 16th, ABL Bio is trading at 32,550 KRW, up 24.95% from the previous day. This marks a 78.85% increase compared to May 27. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.
Today, foreigners have net purchased 106,000 shares of ABL Bio, and institutions have net purchased 35,000 shares, according to preliminary data. Over the past 5 days, individual investors have net purchased 659,456 shares, while foreigners and institutions have net purchased 237,273 shares and net sold 779,674 shares, respectively.
On June 11, ABL Bio was a market topic for its strong performance driven by the advancement of its "bispecific antibody platform technology" transfer.
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Reporters Who First Revealed Jo Jinwoong's Juvenile Offense History Cleared of Juvenile Act Violation"
- Instead of a National Assembly Profile, Now a 'Carpenter'... Ryu Hojung Says "I Couldn't Do a Body Profile Shoot Twice"
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
